Beam Therapeutics Inc (NASDAQ:BEAM) Achieved Almost -6.67% Growth In A Month. Also Looks Good Long Term.
In last trading session, Beam Therapeutics Inc (NASDAQ:BEAM) saw 1.85 million shares changing hands with its beta currently measuring 1.86. Company’s recent per share price